Striatech to Exhibit and Host Q&A Sessions at ARVO Meeting 2024
Striatech is excited to exhibit at the upcoming annual ARVO Meeting in Seattle, Wash, which will be held between the
Read moreStriatech is excited to exhibit at the upcoming annual ARVO Meeting in Seattle, Wash, which will be held between the
Read moreVentus Therapeutics, a US-based clinical-stage biopharmaceutical company leveraging its exclusive structural biology and computational chemistry platform, ReSOLVE™, has disclosed promising
Read moreAbbVie has introduced PRODUODOPA® (foslevodopa/foscarbidopa) in the European Union to address advanced Parkinson’s disease. AbbVie (NYSE: ABBV) recently announced the
Read moreAmerican multinational pharmaceutical company Bristol Myers Squibb and Karuna Therapeutics, Inc. (“Karuna”) have announced that they have entered into a
Read moreAlzheimer’s disease (AD) and Parkinson’s disease (PD) stand as the two most prevalent neurodegenerative disorders, each characterized by the cerebral
Read moreStressMarq Biosciences, a pioneer in the development and commercialization of unique fibrilized and oligomeric protein preparations to propel the study
Read moreA collaboration between StressMarq Biosciences and Gubra has generated a 3D whole-brain light sheet fluorescence imaging model depicting alpha-synuclein pSer129+
Read moreStressMarq manufactures and offers a wide range of products specifically developed to accelerate Parkinson’s disease research. StressMarq’s cutting-edge product range
Read moreIn a recent scientific commentary, Brenda Knox at StressMarq delves into the complex interplay between amyloid-beta plaques and tau neurofibrillary
Read moreStressMarq Biosciences, a prominent leader in the field of neurodegenerative disease research products, is excited to announce its participation in
Read more